SCHEMBL6560207

SCHEMBL6560207

NC(=O)[C@H](C(=O)NC1CC(=O)C(=O)C1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM7 Q14831 2/20 0.37
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
F2 P00734 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA5A P35218 2/20 0.36
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557583 0.86 SLC1A3 (0.37) SLC1A3SLC1A2SLC1A1SMN1; SMN2F2
SCHEMBL5441985 0.79 XIAP (0.39) GRM7SLC1A3SLC1A2SLC1A1SMN1; SMN2
SCHEMBL6559792 0.78 USP2 (0.39) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL6557913 0.76 GBA1 (0.39) SLC1A3SLC1A2SLC1A1F2PRSS1
SCHEMBL6558896 0.72 CYP3A4 (0.37) SLC1A3SLC1A2SLC1A1SMN1; SMN2F2
SCHEMBL7551628 0.72 CTSS (0.49)
SCHEMBL6987075 0.69 CAPN1 (0.36) F2PRSS1PRSS2PRSS3ALDH1A1
SCHEMBL6557593 0.67 KEAP1 (0.41) MMP1MMP2MMP9MMP8MMP13
SCHEMBL6557623 0.66 KMT2A (0.38) SLC1A3SLC1A2SLC1A1SMN1; SMN2F2
SCHEMBL6062861 0.65 PRSS1 (0.49) SLC1A3SLC1A2SLC1A1SMN1; SMN2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed